Xia Xu

862 total citations
20 papers, 712 citations indexed

About

Xia Xu is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Xia Xu has authored 20 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Xia Xu's work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (5 papers). Xia Xu is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (5 papers). Xia Xu collaborates with scholars based in China, Canada and Hong Kong. Xia Xu's co-authors include Xiong Liu, Juan Lü, Chenchen Zhang, Shoujie Chai, Pingli Wang, Yiming Yang, Kai Wang, Ying Yang, Xiangping Li and Lu Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecular Cancer.

In The Last Decade

Xia Xu

20 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xia Xu China	13	496	449	174	74	53	20	712
Aili He China	17	772 1.6×	520 1.2×	189 1.1×	41 0.6×	100 1.9×	73	1.0k
Yingjun Xie China	11	423 0.9×	366 0.8×	121 0.7×	76 1.0×	54 1.0×	20	623
Erika Nakatsuka Japan	9	535 1.1×	488 1.1×	109 0.6×	42 0.6×	118 2.2×	20	742
Shaohua Qu China	8	523 1.1×	522 1.2×	201 1.2×	47 0.6×	46 0.9×	12	777
Guozhong Jiang China	15	405 0.8×	243 0.5×	220 1.3×	111 1.5×	85 1.6×	43	668
Yingqiu Y. Liu United States	7	461 0.9×	260 0.6×	175 1.0×	52 0.7×	72 1.4×	8	649
Liangxian Cao United States	11	510 1.0×	189 0.4×	277 1.6×	60 0.8×	44 0.8×	17	694
Dilu Feng China	14	370 0.7×	219 0.5×	180 1.0×	80 1.1×	99 1.9×	26	649
José L. García-Puche Spain	11	257 0.5×	313 0.7×	258 1.5×	110 1.5×	28 0.5×	21	551
Junjun Sun China	9	577 1.2×	464 1.0×	110 0.6×	57 0.8×	108 2.0×	21	717

Countries citing papers authored by Xia Xu

Since Specialization

Citations

This map shows the geographic impact of Xia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Xu more than expected).

Fields of papers citing papers by Xia Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Xu. The network helps show where Xia Xu may publish in the future.

Co-authorship network of co-authors of Xia Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xia Xu. A scholar is included among the top collaborators of Xia Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xia Xu. Xia Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peng, Yongzheng, et al.. (2023). Autoimmune diseases and gut microbiota: a bibliometric and visual analysis from 2004 to 2022. Clinical and Experimental Medicine. 23(6). 2813–2827. 12 indexed citations

Hu, Jin, Xia Xu, Shuntao Wang, et al.. (2022). Case Report: Implantation of Dedifferentiated to Poorly Differentiated Thyroid Carcinoma After Endoscopic Thyroid Surgery. Frontiers in Oncology. 12. 896942–896942. 4 indexed citations

Xu, Xia, et al.. (2022). Thoracic Endovascular Aortic Repair for Aberrant Subclavian Artery and Stanford Type B Aortic Intramural Hematoma. Frontiers in Surgery. 8. 813970–813970. 3 indexed citations

Xu, Xia, et al.. (2021). Thoracic Endovascular Aortic Repair for Retrograde Type A Aortic Intramural Hematoma. Frontiers in Cardiovascular Medicine. 8. 712524–712524. 4 indexed citations

Zhong, Tingting, et al.. (2021). 266 AK117, a CD47 blocking antibody with robust macrophage activation without red blood cell hemagglutination. SHILAP Revista de lepidopterología. A288–A289. 2 indexed citations

Shen, Zhuojian, et al.. (2020). miR-21 Overexpression Promotes Esophageal Squamous Cell Carcinoma Invasion and Migration by Repressing Tropomyosin 1. Gastroenterology Research and Practice. 2020. 1–10. 15 indexed citations

Liu, Rong‐Zong, Wonshik Choi, Saket Jain, et al.. (2020). The FABP12/PPARγ pathway promotes metastatic transformation by inducing epithelial‐to‐mesenchymal transition and lipid‐derived energy production in prostate cancer cells. Molecular Oncology. 14(12). 3100–3120. 41 indexed citations

Li, Jun, et al.. (2020). Long noncoding RNA NORAD regulates lung cancer cell proliferation, apoptosis, migration, and invasion by the miR-30a-5p/ADAM19 axis.. PubMed. 13(1). 1–13. 22 indexed citations

Xie, Chao, Xia Xu, Bian Wu, Kunyu Yang, & Jing Huang. (2018). Primary pulmonary lymphoepithelioma-like carcinoma in non-endemic region. Medicine. 97(8). e9976–e9976. 6 indexed citations

10.

Li, Haitao, et al.. (2018). Enhanced rapamycin delivery to hemangiomas by lipid polymer nanoparticles coupled with anti-VEGFR antibody. International Journal of Molecular Medicine. 41(6). 3586–3596. 15 indexed citations

11.

Xu, Xia, Juan Lü, Fan Wang, et al.. (2018). Dynamic Changes in Plasma MicroRNAs Have Potential Predictive Values in Monitoring Recurrence and Metastasis of Nasopharyngeal Carcinoma. BioMed Research International. 2018. 1–10. 23 indexed citations

12.

Huang, Bangxing, et al.. (2016). High-Grade Tumor Budding Stratifies Early-Stage Cervical Cancer with Recurrence Risk. PLoS ONE. 11(11). e0166311–e0166311. 27 indexed citations

13.

Kong, Ye, et al.. (2016). RUNX3-mediated up-regulation of miR-29b suppresses the proliferation and migration of gastric cancer cells by targeting KDM2A. Cancer Letters. 381(1). 138–148. 47 indexed citations

14.

Xu, Xia, Shoujie Chai, Pingli Wang, et al.. (2015). Aldehyde dehydrogenases and cancer stem cells. Cancer Letters. 369(1). 50–57. 160 indexed citations

15.

Xu, Xia, Yingjie Zhang, Zhifang Liu, Xinchao Zhang, & Jihui Jia. (2015). miRNA‐532‐5p functions as an oncogenic microRNA in human gastric cancer by directly targeting RUNX3. Journal of Cellular and Molecular Medicine. 20(1). 95–103. 35 indexed citations

16.

Xu, Xia, Wen‐Cheng Xiong, Liduan Zheng, & Jie Yu. (2014). Intramuscular dendritic fibromyxolipoma in a 24-year-old male: A case report and review of the literature. Oncology Letters. 9(2). 583–586. 6 indexed citations

17.

Huang, Hao, Juan Lü, Xiong Liu, et al.. (2014). MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma. Molecular Cancer. 13(1). 186–186. 98 indexed citations

18.

Lü, Juan, Huanan Luo, Xiong Liu, et al.. (2013). miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma. Carcinogenesis. 35(3). 554–563. 86 indexed citations

19.

Li, Yu, Juan Lü, Bao Zhang, et al.. (2013). miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2. Oncology Letters. 5(4). 1223–1228. 70 indexed citations

20.

Zhan, Yiping, Xin‐En Huang, Jie Cao, et al.. (2012). Clinical Study on Safety and Efficacy of Qinin^®(Cantharidin Sodium) Injection Combined with Chemotherapy in Treating Patients with Gastric Cancer. Asian Pacific Journal of Cancer Prevention. 13(9). 4773–4776. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact